GlassScriptPhysician profile
Manaf Seidarabi
NPI 1861440562
$7,368.41
in general payments reported to CMS, 2019-2025
32 companies · $1,269 in 2025
The $1,269 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,489 · 2020: $227 · 2022: $1,285 · 2023: $1,609 · 2024: $1,491 · 2025: $1,269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,371 · Long Term Medical Supply Or Device Loan: $1,997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,371.42 |
| Long Term Medical Supply Or Device Loan | $1,997.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $3,269.69 | 2022-2024 | (2013) Sleep Therapy Modems |
| Ucb, INC. | $591.93 | 2019-2025 | Briviact, Nayzilam, Rystiggo |
| Teva Pharmaceuticals USA, INC. | $504.62 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Abbvie INC. | $409.85 | 2023-2025 | Ubrelvy, Qulipta |
| Emd Serono, INC. | $297.74 | 2019-2025 | |
| Biogen, INC. | $293.31 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Pfizer INC. | $214.99 | 2024-2025 | |
| Lilly USA, LLC | $203.33 | 2019-2025 | Kisunla, Emgality, Zepbound |
| Genzyme Corporation | $144.49 | 2019 | |
| Sunovion Pharmaceuticals INC. | $140.09 | 2019-2020 | |
| Catalyst Pharmaceuticals, INC. | $123.41 | 2023-2025 | Fycompa |
| Acorda Therapeutics, INC | $117.46 | 2019-2022 | |
| Eisai INC. | $114.68 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $104.43 | 2019-2020 | |
| Neurelis, INC. | $96.16 | 2025 | Valtoco |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Argenx US, INC. | $94.30 | 2024-2025 | Vyvgart Hytrulo |
| Amgen INC. | $75.56 | 2019-2020 | |
| Lundbeck LLC | $65.23 | 2019-2025 | Vyepti |
| Supernus Pharmaceuticals, INC. | $56.86 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $52.58 | 2019-2024 | Nuplazid |
| Avanir Pharmaceuticals, INC. | $50.24 | 2019 | |
| Axsome Therapeutics, INC. | $49.29 | 2024-2025 | Sunosi |
| Adamas Pharmaceuticals, INC. | $48.68 | 2019-2020 | |
| Kyowa Kirin, INC. | $42.23 | 2024 | Nourianz |
| Tanabe Pharma America, INC. | $41.38 | 2025 | Radicava |
| Inspire Medical Systems, INC. | $31.31 | 2024 | Inspire |
| Allergan, INC. | $30.12 | 2019-2020 | |
| Cycle Pharmaceuticals INC | $29.91 | 2024-2025 | Tascenso Odt, Bafiertam |
| Hospira, INC. | $23.62 | 2025 | |
| Merz Pharmaceuticals, LLC | $20.61 | 2025 | Inbrija |
| Celgene Corporation | $16.24 | 2023 | Zeposia |
| Vertical Pharmaceuticals, LLC | $14.07 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manaf Seidarabi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.